ICC.V - ICC Labs Inc.

TSXV - TSXV Delayed Price. Currency in CAD
1.85
0.00 (0.00%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close1.85
Open1.84
Bid1.84 x 0
Ask1.86 x 0
Day's Range1.84 - 1.86
52 Week Range0.87 - 2.00
Volume319,732
Avg. Volume933,983
Market Cap260.643M
Beta (3Y Monthly)3.69
PE Ratio (TTM)108.82
EPS (TTM)0.02
Earnings DateNov 27, 2018 - Dec 3, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.92
  • GlobeNewswire6 days ago

    ICC Labs Provides Information About Circular

    ICC Labs Inc. (ICC or the Company) (ICC.V) confirms that the management information circular dated October 3, 2018 (the Circular), form of proxy and other materials with respect to the Company’s proposed plan of arrangement (the Arrangement) with Aurora Cannabis Inc. (Aurora) have been mailed to holders (the ICC Shareholders) of common shares of ICC (the ICC Shares) of record as of September 26, 2018 in accordance with an interim order of the Supreme Court of British Columbia. The Circular has been provided in respect of a meeting (the Meeting) of ICC Shareholders to be held on Tuesday November 6, 2018 at 9:00 a.m. (Toronto time) at the offices of Norton Rose Fulbright Canada LLP located at Royal Bank Plaza, South Tower, Suite 3800, 200 Bay Street, Toronto, Ontario.

  • GlobeNewswire18 days ago

    ICC Labs Obtains Interim Order for Arrangement With Aurora Cannabis

    ICC Labs Inc. (the Company or ICC Labs) (ICC.V) is pleased to announce that it has obtained an interim order of the Supreme Court of British Columbia authorizing, among other things, the holding of the Company’s special meeting of holders (the ICC Shareholders) of common shares (ICC Shares). At the meeting, the ICC Shareholders will be asked to consider and vote on a special resolution (the Arrangement Resolution) approving a statutory plan of arrangement (the Arrangement) whereby, subject to the terms and conditions of an arrangement agreement between the Company and Aurora Cannabis Inc. (Aurora) dated September 8, 2018 (the Arrangement Agreement), Aurora will acquire all of the issued and outstanding ICC Shares.

  • CNW Grouplast month

    IIROC Trading Resumption - ICC

    VANCOUVER , Sept. 10, 2018 /CNW/ - Trading resumes in: Company: ICC Labs Inc. TSX-Venture Symbol: ICC Resumption (ET): 15:30 IIROC can make a decision to impose a temporary suspension (halt) of trading ...

  • CNW Grouplast month

    IIROC Trading Halt - ICC

    VANCOUVER , Sept. 10, 2018 /CNW/ - The following issues have been halted by IIROC: Company: ICC Labs Inc. TSX-Venture Symbol: ICC Reason: Pending News Halt Time (ET): 12:40 IIROC can make a decision to ...

  • GlobeNewswirelast month

    Aurora Cannabis to Acquire South American Market Leader ICC Labs

    WKN: A1C4WM) and ICC Labs Inc. (ICC.V) (ICC) announced today that the companies have entered into a definitive arrangement agreement pursuant to which Aurora intends to acquire all of the issued and outstanding common shares of ICC (the ICC Shares) for $1.95 per share (payable in common shares of Aurora (the Aurora Shares) (the Share Consideration), reflecting an aggregate purchase price of approximately $290 million (the Transaction). The Transaction has been unanimously approved by the Board of Directors of each ICC and Aurora.

  • CNW Grouplast month

    Aurora Cannabis to Acquire South American Market Leader ICC Labs

    WKN: A1C4WM) and ICC Labs Inc. (TSX-V:ICC.V - News) (ICC) announced today that the companies have entered into a definitive arrangement agreement  pursuant to which Aurora intends to acquire all of the issued and outstanding common shares of ICC (the ICC Shares) for $1.95 per share (payable in common shares of Aurora (the Aurora Shares) (the Share Consideration), reflecting an aggregate purchase price of approximately $290 million (the Transaction). The Transaction has been unanimously approved by the Board of Directors of each ICC and Aurora.

  • GlobeNewswire2 months ago

    ICC Labs Files Financial Results for the Second Quarter Ended June 30 and Completes the Construction of Its 124,000 sq. ft. Greenhouse in Colombia to Produce Psychoactive Medicinal Cannabis

    ICC Labs Inc. (“ICC Labs” or the “Company”) (ICC.V) is pleased to announce that it has filed its interim financial results for the second quarter ended June 30, 2018. ICC Labs is also pleased to announce that has completed the construction of its 124,000 sq. ft. greenhouse in Tabio, which is strategically located just north of Bogotá, where the Company intends to produce psychoactive cannabis with up to 20% of tetrahydrocannabinol (THC) for medicinal purposes, subject to approval of the TSX Venture Exchange. The financial statements and management discussion and analysis for the three and six months ended June 30, 2018, are available on the System for Electronic Document Analysis and Retrieval (“SEDAR”) at www.sedar.com and on ICC Labs’ website at www.icclabs.com.

  • GlobeNewswire2 months ago

    ICC Responds to Media Reports

    VANCOUVER, British Columbia, Aug. 23, 2018-- ICC Labs Inc. is aware of a recent Spanish language media report speculating as to a potential transaction involving the acquisition of the Company. The policy ...

  • June Undervalued Stock Picks
    Simply Wall St.4 months ago

    June Undervalued Stock Picks

    Undervalued companies, such as Big 8 Split and ICC Labs, trade at a price less than their true values. Smart investors can make money from this discrepancy by buying theseRead More...

  • CNW Group7 months ago

    IIROC Trading Resumption - ICC

    VANCOUVER , March 28, 2018 /CNW/ - Trading resumes in: Company: ICC Labs Inc. TSX-Venture Symbol: ICC Resumption (ET): 1:30 PM IIROC can make a decision to impose a temporary suspension (halt) of trading ...

  • CNW Group7 months ago

    IIROC Trading Halt - ICC

    VANCOUVER , March 28, 2018 /CNW/ - The following issues have been halted by IIROC: Company: ICC LABS INC. TSX-Venture Symbol: ICC Reason: Pending Company Contact Halt Time (ET): 9:18 AM IIROC can make ...